Glucagon-like peptide-1 receptor agonists linked to a reduced risk of developing asthma among patients with type 2 diabetes.
Saved in:
| Title: | Glucagon-like peptide-1 receptor agonists linked to a reduced risk of developing asthma among patients with type 2 diabetes. |
|---|---|
| Authors: | Cheng YS; Division of Pediatric Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan, ROC.; Graduate Institute of Applied Science and Engineering, Fu-Jen Catholic University, New Taipei, Taiwan, ROC., Chung CH; School of Public Health, National Defense Medical University, Taipei, Taiwan, ROC.; Taiwanese Injury Prevention and Safety Promotion Association, Taipei, Taiwan, ROC.; Department of Medical Research, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan, ROC., Kuo SM; Division of Pediatric Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan, ROC., Lin CP; Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan, ROC., Weng TH; Department of Medical Research, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan, ROC., Su SC; Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan, ROC., Lu CH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan, ROC., Kuo FC; Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan, ROC., Chien WC; School of Public Health, National Defense Medical University, Taipei, Taiwan, ROC.; Taiwanese Injury Prevention and Safety Promotion Association, Taipei, Taiwan, ROC.; Department of Medical Research, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan, ROC., Liang YJ; Graduate Institute of Applied Science and Engineering Department and Institute of Life Science, Fu-Jen University, Number 510, Zhong-Zheng Road, Xin-Zhuang District, New Taipei City 242, Taiwan, ROC., Li PF; Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, No. 325, Sec. 2, Chenggong Road, Neihu District, Taipei City 114, Taiwan, ROC. |
| Source: | Therapeutic advances in endocrinology and metabolism [Ther Adv Endocrinol Metab] 2025 Dec 17; Vol. 16, pp. 20420188251400536. Date of Electronic Publication: 2025 Dec 17 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Publication Country of Publication: United States NLM ID: 101532143 Publication Model: eCollection Cited Medium: Print ISSN: 2042-0188 (Print) Linking ISSN: 20420188 NLM ISO Abbreviation: Ther Adv Endocrinol Metab Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2042-0188 |
|---|---|
| DOI: | 10.1177/20420188251400536 |
